Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Ipsen Pharma (UK)

Femme Max 99 ans
Ipsen Pharma (UK) MAJ Il y a 4 ans

A prospective single-centre single-arm open-label study of the long-term use of a LHRH agonist (Decapeptyl SR 11.25mg) in combination with livial add-back therapy in the management of chronic cyclical pelvic pain in pre-menopausal women Background and study aims Decapeptyl is a synthetic (man-made) hormone that stops the ovaries producing the hormone oestrogen. It can be used to treat disorders that are dependent on oestrogen being ...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations